ASX-listed medical marijuana company AusCann is seeking to raise $30 million for clinical studies and expansion of its manufacturing facilities. Read More
The post Canadian cannabis bigwig to tip fresh funds into Australia’s AusCann appeared first on Dagga Magazine.